Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Hearings Planned For Senate Committee On Aging

This article was originally published in The Pink Sheet Daily

Executive Summary

Sen. Craig wants to "keep CMS on its toes" as it implements the Medicare drug benefit. Craig holds press briefing to discuss the benefits of Medicare Modernization Act on the same day as President Bush's nomination acceptance speech.

You may also be interested in...



Senate Finance Committee Plans Hearing On Medicare Rx Implementation

CMS Administrator Mark McClellan will testify at Sept. 14 hearing to discuss implementing the Medicare drug benefit and Medicare Advantage program. Other witness include PCMA President Mark Merritt and AHIP President Karen Ignagni.

Senate Finance Committee Plans Hearing On Medicare Rx Implementation

CMS Administrator Mark McClellan will testify at Sept. 14 hearing to discuss implementing the Medicare drug benefit and Medicare Advantage program. Other witness include PCMA President Mark Merritt and AHIP President Karen Ignagni.

Once Safety Issues Are Addressed, Rx Importation "Makes Sense," President Bush Says

Outstanding safety concerns are the sole reason for not yet allowing reimportation from Canada, Bush says during Q&A session with voters. By making drug imports a question of resources, he opens the door to approving some version of the practice.

Related Content

Topics

UsernamePublicRestriction

Register

PS060602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel